CD40LG and COVID-19: It may be an imperfection ofthe first generation of serological tests, but current IgM assays have failed todetect a significant fraction of truly infected (qPCR positive) subjects in thefirst 2 weeks from symptoms onset (40).Moreover, about 25% of the COVID-19 patients develop IgM concomitantly or afterthe appearance of IgG (41).